BRIEF-AstraZeneca to collaborate with Lilly on solid tumours clinical trial

* Astrazeneca and lilly to collaborate on immuno-oncology combination clinical trial in solid tumours
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.